Glucocorticoid‐induced osteoporosis: lessons from Cushing's syndrome
- 13 April 2013
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 79 (1), 1-11
- https://doi.org/10.1111/cen.12189
Abstract
Glucocorticoid-induced osteoporosis (GIO) is the most frequent form of secondary bone disorders. Most of our knowledge on its pathogenesis and treatment has been obtained by investigating patients treated with exogenous glucocorticoids. This review will focus on the bone disorder in endogenous Cushing's syndrome, updating recent advances in its pathophysiology, diagnostic aspects and the various predictors which are important in determining bone mineral density (BMD) and fracture risk. We now know strong evidence that beside BMD, bone microarchitecture, one of the most important elements of bone quality, is a key factor in determining fracture risk. Recently, two new methods (spinal deformity index and trabecular bone score) have been shown to be useful markers of bone microarchitecture in GIO. Investigations of GIO in endogenous Cushing's syndrome have also contributed to our understanding on its natural history and reversibility. Relying on recently published guidelines for management of exogenous GIO, a short list of suggestions is provided regarding the optimal diagnostic and therapeutic approach to patients with endogenous GIO.Keywords
This publication has 83 references indexed in Scilit:
- Subclinical Cushing’s syndrome: definition and managementClinical Endocrinology, 2011
- Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosisBone, 2011
- Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal studyJournal of Bone and Mineral Research, 2011
- Effects of Cushing Disease on Bone Mineral Density in a Pediatric PopulationThe Journal of Pediatrics, 2010
- Age-dependence of femoral strength in white women and menJournal of Bone and Mineral Research, 2010
- Looking beyond bone mineral densityAnnals of the New York Academy of Sciences, 2010
- BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolismClinical Endocrinology, 2009
- Microarchitecture, the key to bone qualityRheumatology, 2009
- Molecular mechanisms regulating glucocorticoid sensitivity and resistanceMolecular and Cellular Endocrinology, 2009
- High-dose glucocorticoids increase serum levels of soluble IL-6 receptor α and its ratio to soluble gp130: an additional mechanism for early increased bone resorptionActa Endocrinologica, 2006